Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers

NCT01638598 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim